1. Volume 56, Pages S15-S19 (November 1999)
Use of adsorptive mechanisms in continuous renal replacement therapies in the critically ill 
Ciro Tetta, Rinaldo Bellomo, Alessandra Brendolan, Pasquale Piccinni, Antonio Digito, Maurizio Dan, Marco Irone, Gerhard Lonnemann, Donatella Moscato, Juan Buades, Giuseppe La Greca, Claudio Ronco 
Kidney International 
Volume 56, Pages S15-S19 (November 1999)
DOI: /j s72.16.x
Copyright © 1999 International Society of Nephrology Terms and Conditions

2. Figure 1
Criteria to assess the efficiency of plasma filtration versus ultrafiltration to study in vitro the adsorption of sepsis-associated mediators tumor necrosis factor-α (TNF-α), interlukin-1β (IL-1β), IL-8, and platelet activating factor (PAF). Symbols are: () % removed mass; () % drop in concentration; (▪) clearance.
Kidney International  , S15-S19DOI: ( /j s72.16.x)
Copyright © 1999 International Society of Nephrology Terms and Conditions

3. Figure 2
Plasma treatment in sepsis including the criteria to assess the efficiency of the sorbent.
Kidney International  , S15-S19DOI: ( /j s72.16.x)
Copyright © 1999 International Society of Nephrology Terms and Conditions

4. Figure 3
Development of plasma filtration coupled with sorbent adsorption (CPFA).
Kidney International  , S15-S19DOI: ( /j s72.16.x)
Copyright © 1999 International Society of Nephrology Terms and Conditions

5. Figure 4
Criteria used to assess the efficiency of innovative techniques to treat sepsis.
Kidney International  , S15-S19DOI: ( /j s72.16.x)
Copyright © 1999 International Society of Nephrology Terms and Conditions